(Q57422687)

5

Stefan D. Anker

0 references

Dirk J van Veldhuisen

9

Dirk J. van Veldhuisen

0 references

William T Abraham

2

William T. Abraham

0 references

Scott M. Wasserman

8

Scott M. Wasserman

0 references

author name string

Marc Klapholz

1

0 references

Jalal K. Ghali

3

0 references

Beat Knusel

6

0 references

Yan Sun

European Journal of Heart Failure

7

0 references

publication date

29 October 2009

0 references

published in

0 references

volume

11

0 references

issue

11

0 references

page(s)

1071-1077

0 references

cites work

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Prevalence of anemia and effects on mortality in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Anemia and mortality in heart failure patients a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Effect of anemia on exercise tolerance in chronic heart failure in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Chronic kidney disease in patients with cardiac disease: a review of evidence-based treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Exploring relative mortality and epoetin alfa dose among hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130

Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP130